Afinitor and Zygomycosis - a phase IV clinical study of FDA data

Summary:

Zygomycosis is reported only by a few people who take Afinitor.

The phase IV clinical study analyzes which people take Afinitor and have Zygomycosis. It is created by eHealthMe based on reports of 39,807 people who have side effects while taking Afinitor from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

39,807 people reported to have side effects when taking Afinitor.
Among them, 2 people (0.01%) have Zygomycosis.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.

What is Zygomycosis?

Zygomycosis (an infection caused by fungus) is found to be associated with 639 drugs and 602 conditions by eHealthMe.

Number of Afinitor and Zygomycosis reports submitted per year:

Gender of people who have Zygomycosis when taking Afinitor *:

female: 0.0 %
male: 100 %

Age of people who have Zygomycosis when taking Afinitor *:

Common drugs people take besides Afinitor *:

Vancomycin: 2 people, 100.00%
Cytarabine: 1 person, 50.00%

Common side effects people have besides Zygomycosis *:

Weakness: 2 people, 100.00%
Urine Output - Decreased: 2 people, 100.00%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 2 people, 100.00%
Bone Marrow Failure: 2 people, 100.00%
Confusional State: 2 people, 100.00%
Coughing Up Blood: 2 people, 100.00%
Enterovesical Fistula: 2 people, 100.00%
Febrile Infection (infection with temperature rise): 2 people, 100.00%
Fever: 2 people, 100.00%
Intestinal Obstruction: 2 people, 100.00%

Common conditions people have *:

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Afinitor and have Zygomycosis?

Check whether Zygomycosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Zygomycosis and when was it recovered:

Zygomycosis in Afinitor

Expand to all the drugs that have ingredients of everolimus:

Zygomycosis and drugs with ingredients of everolimus

Alternative drugs to, pros and cons of Afinitor:

Afinitor (39,878 reports)

Common Afinitor side effects:

Death: 5,716 reports
Fatigue (feeling of tiredness): 4,180 reports
Diarrhea: 3,836 reports
Breathing difficulty: 2,776 reports
Rashes (redness): 2,725 reports
Pneumonia: 2,409 reports

Browse all side effects of Afinitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Zygomycosis treatments and more:

Zygomycosis (3,968 reports)

COVID vaccines that are related to Zygomycosis:

Common drugs associated with Zygomycosis:

All the drugs that are associated with Zygomycosis:

Zygomycosis (639 drugs)

Common conditions associated with Zygomycosis:

All the conditions that are associated with Zygomycosis:

Zygomycosis (602 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.